tiprankstipranks
Sernova Secures Over $5M in Funding, Preps for EASD Update
Company Announcements

Sernova Secures Over $5M in Funding, Preps for EASD Update

Story Highlights

Sernova (TSE:SVA) has released an update.

Don't Miss our Black Friday Offers:

Sernova Corp., a clinical-stage biotech firm, has successfully closed an over-subscribed private placement, raising over $5.2 million. The company, known for its Cell Pouch System for treating chronic diseases like diabetes, is set to present recent clinical study data at the EASD Annual Meeting in Spain.

For further insights into TSE:SVA stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskSernova Bolsters Leadership for Bio-hybrid Organ Programs
TipRanks Canadian Auto-Generated NewsdeskSernova Highlights Cell Therapy Advances at Industry Conference
TipRanks Canadian Auto-Generated NewsdeskSernova Strengthens Board with Biotech Expertise
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App